###begin article-title 0
Positive Reciprocal Regulation of Ubiquitin C-Terminal Hydrolase L1 and beta-Catenin/TCF Signaling
###end article-title 0
###begin p 1
Conceived and designed the experiments: AB WY RL JS. Performed the experiments: AB WY AG RL CW JS. Analyzed the data: AB WY JP JS. Wrote the paper: AB JP JS.
###end p 1
###begin p 2
###xml 291 298 291 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 207 212 <span type="species:ncbi:9606">human</span>
Deubiquitinating enzymes (DUBs) are involved in the regulation of distinct critical cellular processes. Ubiquitin C-terminal Hydrolase L1 (UCH L1) has been linked to several neurological diseases as well as human cancer, but the physiological targets and the regulation of UCH L1 expression in vivo have been largely unexplored. Here we demonstrate that UCH L1 up-regulates beta-catenin/TCF signaling: UCH L1 forms endogenous complexes with beta-catenin, stabilizes it and up-regulates beta-catenin/TCF-dependent transcription. We also show that, reciprocally, beta-catenin/TCF signaling up-regulates expression of endogenous UCH L1 mRNA and protein. Moreover, using ChIP assay and direct mutagenesis we identify two TCF4-binding sites on the uch l1 promoter that are involved in this regulation. Since the expression and deubiquitinating activity of UCH L1 are required for its own basic promoter activity, we propose that UCH L1 up-regulates its expression by activation of the oncogenic beta-catenin/TCF signaling in transformed cells.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 104 107 104 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005955-Finley1">[1]</xref>
###xml 298 301 295 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Wnt</italic>
###xml 310 313 307 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005955-Barker1">[2]</xref>
###xml 315 318 312 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005955-Brembeck1">[3]</xref>
###xml 472 475 466 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005955-Barker2">[4]</xref>
###xml 555 560 546 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c-myc</italic>
###xml 562 570 553 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin D</italic>
###xml 572 577 563 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c-jun</italic>
###xml 579 587 570 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">survivin</italic>
###xml 693 696 681 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005955-Clevers1">[5]</xref>
The lifetime of many central components of intracellular signaling is regulated by the ubiquitin system [1]. Among them is the multifunctional molecule beta-catenin, which plays a dual role in cells as a major structural component of cell-cell adherens junctions and as a signaling molecule in the Wnt pathway [2], [3]. As a part of the transcriptional machinery beta-catenin provides a transactivation domain in a heterodimeric complex with TCF/Lef transcription factors [4]. beta-catenin/TCF/Lef-dependent transcription induces expression of genes such c-myc, cyclin D, c-jun, survivin and others, which indicates that beta-catenin/TCF/Lef signaling up-regulates oncogenic cellular pathways [5].
###end p 4
###begin p 5
###xml 207 210 201 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005955-Kikuchi1">[6]</xref>
###xml 331 334 322 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005955-Shackelford1">[7]</xref>
###xml 439 442 427 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005955-Taya1">[8]</xref>
The nonjunctional pool of beta-catenin is normally a target for destruction by the ubiquitin-proteasome system, and the process of beta-catenin regulation through ubiquitination has been studied intensively [6]. The reverse process - deubiquitination-has also been implicated in the regulation of beta-catenin intracellular levels [7], and the deubiquitinating enzyme Fam/USP9X was identified as a candidate for beta-catenin stabilization [8].
###end p 5
###begin p 6
###xml 246 249 246 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005955-Larsen1">[9]</xref>
###xml 458 462 458 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005955-Betarbet1">[10]</xref>
###xml 464 468 464 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005955-Setsuie1">[11]</xref>
###xml 598 602 598 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005955-Liu1">[12]</xref>
###xml 690 697 690 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 768 772 768 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005955-Osaka1">[13]</xref>
Among the large family of DUBs are Ubiquitin C-terminal Hydrolases-cysteine hydrolases that contain the typical active site triad of cysteine, histidine, and aspartic acid and that catalyze hydrolysis of C-terminal esters and amides of ubiquitin [9]. One of them - UCH L1 - is abundantly (up to 2% of the total soluble protein) expressed in normal brain tissue, and mutations in the UCH L1 gene have been associated with Parkinson's and Alzheimer's diseases [10], [11]. In addition to its deubiquitinating activity, UCH L1 has been shown to exhibit dimerization-dependent ubiquitin ligase activity [12]. Another function of UCH L1 in neurons involves binding and stabilizing mono-ubiquitin in vivo, and this function is independent of the enzymatic activity of UCH L1 [13].
###end p 6
###begin p 7
###xml 94 98 94 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005955-Hibi1">[14]</xref>
###xml 100 104 100 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005955-Otsuki1">[15]</xref>
###xml 106 110 106 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005955-LoefflerRagg1">[16]</xref>
###xml 112 116 112 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005955-Ovaa1">[17]</xref>
###xml 118 122 118 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005955-Yang1">[18]</xref>
###xml 124 128 124 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005955-Miyoshi1">[19]</xref>
###xml 325 329 325 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005955-Kim1">[20]</xref>
###xml 399 403 399 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005955-Rolen1">[21]</xref>
###xml 603 609 603 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">uch l1</italic>
###xml 665 669 665 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005955-Trowern1">[22]</xref>
###xml 671 675 671 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005955-Mann1">[23]</xref>
###xml 677 681 677 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005955-Day1">[24]</xref>
###xml 760 764 760 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005955-Joaquin1">[25]</xref>
###xml 815 821 815 821 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">uch l1</italic>
###xml 844 852 844 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 857 864 857 864 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 864 868 864 868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005955-Long1">[26]</xref>
###xml 892 898 892 898 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">uch l1</italic>
###xml 479 484 <span type="species:ncbi:9606">human</span>
###xml 808 814 <span type="species:ncbi:10090">murine</span>
There is also growing evidence indicating that UCH L1 is overexpressed in a number of cancers [14], [15], [16], [17], [18], [19], which might be associated with a poor prognosis in some of these cancers. Recent data support this hypothesis, implicating UCH L1 in the up-regulation of metastasis in non-small cell lung cancer [20], and in the proliferation and invasive capacity of malignant B-cells [21]. The possible involvement of UCH L1 in the pathogenesis and progression of human cancer raises the question of how expression of UCH L1 is regulated in transformed cells. The minimal promoter of the uch l1 gene was cloned and partially characterized in neurons [22], [23], [24], and B-Myb, a transcription factor implicated in the regulation of cell cycle [25], has been shown to stimulate expression of murine uch l1 on the promoter level in vitro and in vivo[26], but the regulation of uch l1 expression in cancer cells is still largely unexplored.
###end p 7
###begin p 8
Here we demonstrate a positive feedback between UCH L1 and oncogenic beta-catenin/TCF signaling, providing evidence that in transformed cells UCH L1 up-regulates its own expression through beta-catenin/TCF-dependent transcription.
###end p 8
###begin title 9
Results and Discussion
###end title 9
###begin p 10
###xml 208 211 193 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005955-Shackelford1">[7]</xref>
###xml 213 217 198 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005955-Shackelford2">[27]</xref>
###xml 394 401 376 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005955-g001">Fig. 1A</xref>
###xml 632 639 608 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005955-g001">Fig. 1B</xref>
###xml 779 786 752 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005955-g001">Fig. 1B</xref>
Previously we have demonstrated that in virus-transformed B-cells beta-catenin is physically associated with an active DUB with a molecular weight of approximately26 kDa, and proposed that this DUB is UCH L1 [7], [27]. To verify this suggestion, we immunoprecipitated with specific antibodies endogenous UCH L1 and beta-catenin from lymphoid KR4 and epithelial 293 cells. Western blots of IPs (Fig. 1A) demonstrate that beta-catenin and UCH L1 form endogenous complexes in cell lines of different origin. Additionally, we performed immunofluorescent co-staining of endogenous and overexpressed beta-catenin and UCH L1 in 293 cells (Fig. 1B). UCH L1 and beta-catenin were predominantly co-localized in the nucleus, although some cytoplasmic staining for UCH L1 was also observed (Fig. 1B, left).
###end p 10
###begin title 11
UCH L1 is physically associated with beta-catenin.
###end title 11
###begin p 12
###xml 1029 1037 1011 1019 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 171 176 <span type="species:ncbi:10090">Mouse</span>
###xml 181 187 <span type="species:ncbi:9986">rabbit</span>
###xml 630 637 <span type="species:ncbi:10703">C. beta</span>
A. Endogenous beta-catenin or UCH L1 were immunoprecipitated from KR4 (left) and 293 (right) cells. IPs were resolved in 10-12% PAGE and probed with indicated antibodies. Mouse and rabbit normal immunoglobulins were used as controls for IPs. B. Left panel: nuclear co-localization of UCH L1 and beta-catenin. 293 cells were fixed in 4% PFA and double-immunostained with UCH L1 and beta-catenin antibodies and red and green fluorescent secondary antibodies. Right panel: 293 cells were transfected with wild type HA-UCH L1 and myc-beta-catenin expression vectors. After 24 h cells were fixed and probed with HA and myc antibodies. C. beta-catenin is associated with wild type UCH L1, but not with inactive UCH L1 mutants. 293 cells were transfected with wild type and HA-UCH L1 mutants C90S and H161D, and UCH L1 was immunoprecipitated with HA antibody 48 h after transfection. IPs were resolved in 12% PAGE, transferred to PVDF membrane and probed with beta-catenin antibody. Enzymatic activity of UCH L1 mutants was verified by in vitro hydrolysis of Ub-AMC (right panel).
###end p 12
###begin p 13
###xml 276 283 270 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005955-g001">Fig. 1B</xref>
###xml 425 429 419 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005955-Caballero1">[28]</xref>
Similar staining was observed in A-431 carcinoma cell line (). Co-immunostaining with HA and myc antibodies after co-transfection with HA-UCH L1 and myc-beta-catenin expression vectors revealed similar, mostly nuclear co-localization of overexpressed UCH L1 and beta-catenin (Fig. 1B, right). Nuclear localization of UCH L1 (PGP9.5) was also observed in lung cancer cell line H1299, where UCH L1 can bind Jab1/Kip1 complexes [28].
###end p 13
###begin p 14
###xml 125 128 125 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005955-Larsen1">[9]</xref>
###xml 429 432 426 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005955-Larsen1">[9]</xref>
###xml 536 543 530 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005955-g001">Fig. 1C</xref>
###xml 741 748 735 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005955-g001">Fig. 1C</xref>
The conserved cysteine 90 and histidine 161 in UCH L1 are the necessary catalytic residues for its deubiquitinating activity [9]. We attempted to determine whether the deubiquitinating activity of UCH L1 is important for its ability to form a complex with beta-catenin. After overexpression of HA-UCH L1 wild type and mutants C90S and H161D (with cysteine 90 and histidine 161 converted to serine and aspartic acid, respectively [9]), UCH L1 was immunoprecipitated from the cells and the precipitates probed with beta-catenin antibody (Fig. 1C, left). Deubiquitinating activity of overexpressed HA-UCH L1 proteins was tested by hydrolysis of the Ub-AMC substrate, which confirmed that enzymatic activity of both C90S and H161D was impaired (Fig. 1C, right). The results indicate that beta-catenin is associated preferentially with wild type UCH L1, but not with enzymatically inactive UCH L1 mutants, indicating that the deubiquitinating activity of UCH L1 is required for the molecular events that precede its association with beta-catenin.
###end p 14
###begin p 15
###xml 173 193 170 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">Material and Methods</xref>
###xml 208 215 205 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005955-g002">Fig. 2A</xref>
###xml 571 578 559 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005955-g002">Fig. 2B</xref>
###xml 1130 1138 1106 1114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1154 1162 1130 1138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1191 1198 1164 1171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005955-g002">Fig. 2C</xref>
###xml 1252 1259 1225 1232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005955-g002">Fig. 2C</xref>
###xml 1700 1707 1661 1668 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1712 1720 1673 1681 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
To investigate the possible role of UCH L1 expression in the regulation of beta-catenin levels, we created 293 cell lines stably expressing two different UCH L1 siRNAs (see Material and Methods). As shown in Fig. 2A, the inhibition of UCH L1 protein expression correlates with reduction of beta-catenin levels. To determine whether UCH L1 expression affects beta-catenin ubiquitin-dependent proteasomal degradation, we immunoprecipitated endogenous beta-catenin from control and UCH L1 siRNA-expressing cells in the presence or absence of the proteasome inhibitor MG101 (Fig. 2B). Western blot analysis demonstrates that while without the inhibitor the amount of beta-catenin is reduced in UCH L1 siRNA-expressing cells (compare lanes 3 and 5 to lane 1), the amount of accumulated beta-catenin in the presence of MG101 is greater in the cells where UCH L1 expression is inhibited (compare lanes 4 and 6 to lane 2). These results indicate the involvement of UCH L1 in the regulation of beta-catenin ubiquitination, and suggest the possibility of direct deubiquitination of beta-catenin by UCH L1. To test this possibility, we used in vitro-translated and in vitro-ubiquitinated beta-catenin (Fig. 2C, lanes 4 and 1) as substrate for UCH L1. As shown in Fig. 2C, lanes 2 and 3, the addition of purified UCH L1 results in the disappearance of high molecular weight forms of beta-catenin. These results point to beta-catenin as a plausible substrate for UCH L1, although they do not eliminate the possibility that UCH L1 effects beta-catenin degradation indirectly. For example, deubiquitination of other targets could result in impaired ubiquitination or proteasomal degradation of beta-catenin in both in vivo and in vitro systems. Nevertheless, the observation that beta-catenin levels depend on UCH L1 expression raised the question of whether UCH L1 affects beta-catenin's function as a transcriptional co-activator.
###end p 15
###begin title 16
UCH L1 up-regulates beta-catenin signaling.
###end title 16
###begin p 17
###xml 960 968 939 947 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 987 995 963 971 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1032 1052 1008 1028 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">Material and Methods</xref>
###xml 1178 1186 1151 1159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in-vitro</italic>
###xml 785 790 <span type="species:ncbi:10090">Mouse</span>
A. Reduction of expression of UCH L1 correlates with decrease in beta-catenin protein levels. 293 cells were transfected with control GFP siRNA or two UCH L1 siRNAs in pRS vector and maintained in medium containing puromycin. After 3 weeks of selection total lysates from control- and si1/2 UCH L1-transfected cells were resolved in 12% PAGE, transferred to PVDF membrane and probed with beta-catenin and UCH L1 antibodies. B. More beta-catenin accumulates in UCH L1 siRNA-expressing cells in the presence of proteasome inhibitor. Stable 293 cell lines expressing control and UCH L1 siRNAs were treated for 4 h with 25 mM MG101 or DMSO as negative control. beta-catenin was immunoprecicpitated from total lysates, IPs were resolved in 10% PAGE and probed with beta-catenin antibodies. Mouse normal immunoglobulins were used as control for IPs. Arrow heads indicate ubiquitinated forms of beta-catenin. C. UCH L1 is involved in deubiquitination of beta-catenin in vitro. beta-catenin was in vitro-translated (lane 4) as described in Material and Methods. To induce further ubiquitination equal amounts of translated beta-catenin were pre-incubated with Ub mix for 30 min, and an in-vitro deubiquitination reaction was carried out in the absence (lane 1) or presence of 2 or 4 mM recombinant UCH L1 (lanes 2 and 3). Western blot was performed with beta-catenin antibody. D. Deubiquitinating activity of UCH L1 is required for TCF4 transcriptional activity. UCH L1 wild type or UCH L1 inactive mutants C90S and H161D were co-transfected with either TOPFlash or FOPFlash into 293 and 3T3 cells. Luciferase activity and expression of HA-UCH L1 proteins were determined 48 h post-transfection. Where indicated, cells were treated with 25 mM LiCl 6 h before harvesting. The data represent two independent experiments prepared in triplicate and normalized to FOPFlash activity.
###end p 17
###begin p 18
###xml 118 125 115 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005955-g002">Fig. 2D</xref>
###xml 280 287 277 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005955-g002">Fig. 2D</xref>
###xml 383 387 380 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005955-vandeWetering1">[29]</xref>
###xml 393 414 390 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">Materials and Methods</xref>
###xml 559 566 556 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005955-g002">Fig. 2D</xref>
###xml 711 715 702 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005955-Jope1">[30]</xref>
###xml 869 876 857 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005955-g002">Fig. 2D</xref>
###xml 994 1001 979 986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005955-g002">Fig. 2D</xref>
###xml 1485 1492 1461 1468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005955-g002">Fig. 2D</xref>
To examine this possibility, we used luciferase reporter assays to analyze beta-catenin/TCF transcriptional activity (Fig. 2D). We utilized HEK 293 and NIH 3T3 cells expressing high and low levels of endogenous UCH L1, which were confirmed by RT-PCR with UCH L1 specific primers (Fig. 2D, right). The cells were co-transfected with reporter plasmids containing binding sites for TCF [29] (see Materials and Methods), along with wild type and enzymatically inactive UCH L1 mutants (expression of UCH L1 proteins was confirmed by western blot with HA antibody, Fig. 2D, top panel). As a positive control for activation of beta-catenin-dependent transcription, we used the GSK3beta pharmacological inhibitor, LiCl [30]. Overexpression of wild type UCH L1 had very little, if any, effect on the basic or LiCl-induced beta-catenin/TCF transcriptional activity in 293 cells (Fig. 2D, left), but in 3T3 cells, the expression of wild type UCH L1 increased beta-catenin/TCF transcription significantly (Fig. 2D, right). These results might be explained by different endogenous levels of UCH L1 in 293 and 3T3 cells: so that additional overexpression could not add much to beta-catenin/TCF activity in 293 cells, whereas in 3T3 cells which have very low endogenous UCH L1, the effect of exogenous UCH L1 on beta-catenin/TCF signaling was more profound. Importantly, expression of the DUB-inactive mutants of UCH L1 C90S and H161D inhibited beta-catenin/TCF reporter activity in both cell lines (Fig. 2D), indicating that beta-catenin/TCF transcriptional activity depends on the deubiquitinating activity of UCH L1.
###end p 18
###begin p 19
###xml 356 361 350 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c-myc</italic>
###xml 363 372 357 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cyclin D1</italic>
###xml 374 385 368 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">fibronectin</italic>
###xml 390 401 384 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">stromelysin</italic>
Additional information supporting the hypothesis of UCH L1-dependent regulation of beta-catenin/TCF signaling was provided from gene expression profiling of stable 293 cell lines expressing control and UCH L1 siRNA: inhibition of UCH L1 reveals reduced expression of several known physiological targets of beta-catenin/TCF transcriptional activity such as c-myc, cyclin D1, fibronectin and stromelysin (Bheda. A, unpublished data).
###end p 19
###begin p 20
###xml 95 101 95 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">uch l1</italic>
###xml 298 309 295 306 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TTTGA-3&#8242;</named-content>
###xml 362 366 359 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005955-Riese1">[31]</xref>
###xml 432 438 426 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">uch l1</italic>
###xml 599 620 593 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">Materials and Methods</xref>
###xml 635 641 629 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">uch l1</italic>
###xml 647 651 641 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005955-Mann1">[23]</xref>
###xml 629 634 <span type="species:ncbi:9606">human</span>
The observation that UCH L1 expression is elevated in malignant tumor cells indicates that the uch l1 gene might be subject to transcriptional regulation during cellular transformation by oncogenic pathways such as beta-catenin/TCF. Analysis of the uch l1 promoter using Patch 1.0 has revealed two 5'-TTTGA-3' putative Lef-1 binding sites on the negative strand [31], pointing to the beta-catenin/TCF/Lef complex as a candidate for uch l1 gene regulation. To examine this possibility, we utilized a reporter construct carrying the luciferase gene under the direction of the 5' minimal promoter (see Materials and Methods) of the human uch l1 gene [23].
###end p 20
###begin p 21
###xml 161 167 158 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">uch l1</italic>
###xml 262 269 259 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005955-g003">Fig. 3A</xref>
###xml 578 585 575 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005955-g003">Fig. 3B</xref>
First, we have analyzed uch l1 promoter activity in cell lines stably expressing UCH L1 siRNAs: if our hypothesis about beta-catenin/TCF-dependent regulation of uch l1 is right, then UCH L1 expression should affect its own promoter activity. Indeed, as shown in Fig. 3A, uch l1 promoter (Uchl1p-Luc) activity is significantly lower in cells with a reduced amount of UCH L1. To determine whether UCH L1 deubiquitinating activity is required for its promoter activity we overexpressed wild type and inactive UCH L1 mutants along with the Uchl1p-Luc reporter in control 293 cells (Fig. 3B). Although UCH L1 proteins were expressed at similar levels, uch l1 promoter activity was much lower in the presence of C90S and H161D UCH L1 mutants, indicating that the deubiquitinating activity of UCH L1 is necessary for its promoter activation.
###end p 21
###begin title 22
UCH L1 regulates its promoter activity through beta-catenin/TCF signaling.
###end title 22
###begin p 23
###xml 195 216 195 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">Materials and Methods</xref>
###xml 752 759 <span type="species:ncbi:10703">C. beta</span>
A. Expression of UCH L1 is necessary for its promoter activity. Stable 293 cell lines expressing control GFP siRNA and two UCH L1 siRNAs were co-transfected with Uchl1p-Luc reporter plasmid (see Materials and Methods); 48 h post-transfection luciferase activity was measured and normalized to beta-gal activity. Reduction in UCH L1 expression was verified by Western blotting. B. Deubiquitinating activity of UCH L1 is required for its promoter activity. Wild type UCH L1 or UCH L1 mutants C90S and H161D expression vectors were transfected into 293 cells along with Uchl1p-Luc reporter. Luciferase assays were performed 24 h post-transfection. The data represent two independent experiments prepared in triplicate and normalized to beta-gal activity. C. beta-catenin-binding N-terminus of TCF4 is required for TCF4-dependent activation of UCH L1 promoter. Wild type or deltaN TCF4 expression vectors were co-transfected along with Uchl1p-Luc reporter into 293 (left) and 3T3 (right) cells. Luciferase activity and expression of Flag-TCF4 proteins was determined. Where indicated, cells were treated with 25 mM LiCl 6 hour before harvesting. The data represent two independent experiments prepared in triplicate and are normalized for beta-gal activity. D. Reduction of beta-catenin expression decreases UCH L1 protein levels. 293 cells were transiently transfected with two beta-catenin siRNAs in pSUPER.retro vector. Protein levels of beta-catenin and UCH L1 were determined by Western blotting 48 h post-transfection. E. Treatment with LiCl induces UCH L1 expression in 3T3 cells. Cells were treated with 25 mM LiCl for 24 h, total RNA isolated, and real-time PCR analysis with specific primers for UCH L1 was performed (left). Total lysates from the same cells were separated in 12% PAGE, transferred to PVDF membrane and probed with UCH L1 antibody (right).
###end p 23
###begin p 24
###xml 220 224 214 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005955-Roose1">[32]</xref>
###xml 432 439 423 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005955-g003">Fig. 3C</xref>
###xml 705 712 696 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005955-g003">Fig. 3C</xref>
###xml 933 940 924 931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005955-g003">Fig. 3C</xref>
To determine whether beta-catenin/TCF transcription up-regulates the uch l1 promoter, we tested Flag-tagged TCF4 wild type and a transcriptionaly inactive N-terminal deletion mutant (dN-TCF4) unable to bind beta-catenin [32], for their ability to affect Uchl1p-Luc reporter activity in the presence or absence of the beta-catenin activator LiCl in 293 cells (high levels of endogenous UCH L1) and 3T3 cells (low endogenous levels) (Fig. 3C). Overexpression of wild type TCF4 alone had little stimulatory effect on the uch l1 promoter in both cell lines, but wt-TCF4 significantly increased LiCl-dependent activation of uch l1 promoter with a much more profound effect in 3T3 than in 293 cells. Results in Fig. 3C, also demonstrate that the N-terminal deletion mutant of TCF4 inhibited uch l1 promoter activity in both cell lines, even in the presence of LiCl (expression levels of wt-TCF4 and dN-TCF4 were confirmed by western blot (Fig. 3C, top)). Together, these results indicate that TCF4 up-regulates the uch l1 promoter and the effect depends on its ability to bind beta-catenin.
###end p 24
###begin p 25
###xml 281 288 272 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005955-g003">Fig. 3D</xref>
###xml 535 542 520 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005955-g003">Fig. 3E</xref>
###xml 667 674 649 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005955-g003">Fig. 3E</xref>
###xml 695 702 677 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005955-g003">Fig. 3E</xref>
To confirm the role of beta-catenin signaling in the up-regulation of endogenous UCH L1 expression, we employed two different approaches. First, inhibition of beta-catenin expression by transient transfection of beta-catenin siRNAs in 293 cells (expressing high levels of UCH L1): Fig. 3D shows that a reduction of beta-catenin expression by both siRNAs resulted in decreased levels of endogenous UCH L1 protein. Second, activation of beta-catenin signaling in 3T3 cells (express very low levels of UCH L1) by 25 mM LiCl for 24 hours: Fig. 3E demonstrates that the activation of beta-catenin with LiCl results in a significant increase of both endogenous UCH L1 RNA (Fig. 3E, left) and protein (Fig. 3E, right) levels.
###end p 25
###begin p 26
###xml 315 322 312 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005955-g004">Fig. 4A</xref>
###xml 550 557 547 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005955-g004">Fig. 4A</xref>
###xml 680 687 674 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005955-g004">Fig. 4A</xref>
To determine whether the beta-catenin/TCF complex up-regulates UCH L1 expression through direct binding to its promoter, we performed a ChIP assay using the TCF4 antibody followed by DNA isolation and PCR with primers for both putative TCF/Lef sites on the uch l1 promoter in lymphoid KR4 and epithelial 293 cells (Fig. 4A). Non-immunoprecipitated chromatin was used as an input control and normal IgG as a negative control. In lymphoid KR4 cells, TCF4 binding to both putative sites on the uch l1 promoter was detected without additional treatment (Fig. 4A, left); however in 293 cells TCF4-DNA binding was clearly observed after additional activation of beta-catenin with LiCl (Fig. 4A, right).
###end p 26
###begin title 27
TCF/Lef factors up-regulate UCH L1 expression through direct binding to its promoter.
###end title 27
###begin p 28
###xml 405 426 405 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">Materials and Methods</xref>
###xml 680 701 677 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s3">Materials and Methods</xref>
A. TCF4 binds to endogenous uch l1 promoter. ChIP/PCR analysis was performed to determine binding of TCF4 factor to two putative binding sites on uch l1 promoter (left) with the use of specific TCF4 antibody in KR4 or 293 cells treated with 25 mM LiCl. Normal IgGs were used as a negative controls in IPs. PCR reactions were performed with primers targeting TCF4 binding sites on the uch l1 promoter (see Materials and Methods), and amplified DNA products were resolved in 2% agarose gel. B. Mutations in TCF/Lef putative sites inhibit beta-catenin/TCF4-dependent activation of the uch l1 promoter. Site-directed mutagenesis of TCF/Lef binding sites was performed as described in Materials and Methods. 3T3 cells were transfected with Uchl1p-Luc wild type and mutant reporter plasmids in the presence or absence of TCF4 expression vector. Luciferase assays were performed 48 h post-transfection and are normalized to beta-gal activity. Where indicated 25 mM LiCl was added to the cells 6 h before harvesting. Expression of TCF4 was confirmed by Western blotting.
###end p 28
###begin p 29
###xml 375 382 372 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005955-g004">Fig. 4B</xref>
###xml 607 614 601 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005955-g004">Fig. 4B</xref>
###xml 760 767 754 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005955-g004">Fig. 4B</xref>
###xml 1092 1099 1086 1093 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005955-g004">Fig. 4B</xref>
###xml 1515 1519 1500 1504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005955-Forde1">[33]</xref>
To verify the significance of the putative TCF/Lef binding sites for beta-catenin/TCF-dependent activation of the uch l1 promoter, we mutated each of two sites in the promoter, as well as both sites using the wild type uch l1 promoter reporter (UCHL1p-WT) as a template. We transiently transfected wild type and mutant reporters into 3T3 cells and compared their activities (Fig. 4B). To activate beta-catenin/TCF signaling, we used co-expression of wild type TCF4, treatment with LiCL, or the combination of both. TCF4 itself was able to activate only UCHL1p-WT, but not any of the three mutant reporters (Fig. 4B, second column in each group). In the presence of LiCl, mutations in each putative TCF/Lef site resulted in a decrease of the promoter activity (Fig. 4B, third column in each group). The combination of TCF4 and LiCl had the strongest cumulative effect on the wild type promoter (UCHL1p-WT). Mutations in each (with a slightly more profound effect on the double-mutant) putative TCF/Lef binding site significantly reduced TCF4/LiCl-dependent activation of Uchl1p-Luc reporters (Fig. 4B, fourth column of each group). Taken together these results identify the uch l1 promoter as a direct target of beta-catenin/TCF/Lef transcriptional activity. It is worth noticing, that although mutations in each or both TCF/Lef sites on the uch l1 promoter reduce promoter activity in the presence of LiCl, they do not reduce activity to the basal level. Since LiCl activates beta-catenin by inhibition of GSK3beta [33], the result suggests that other GSK3beta-dependent pathways are involved in the regulation of the uch l1 promoter, in addition to beta-catenin/TCF signaling.
###end p 29
###begin p 30
###xml 421 425 418 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005955-Mandelker1">[34]</xref>
###xml 427 431 424 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005955-OkochiTakada1">[35]</xref>
###xml 433 437 430 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005955-Fukutomi1">[36]</xref>
###xml 547 551 544 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005955-Hibi1">[14]</xref>
###xml 553 557 550 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005955-Otsuki1">[15]</xref>
###xml 559 563 556 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005955-LoefflerRagg1">[16]</xref>
###xml 565 569 562 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005955-Ovaa1">[17]</xref>
###xml 571 575 568 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005955-Yang1">[18]</xref>
###xml 577 581 574 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005955-Miyoshi1">[19]</xref>
###xml 583 587 580 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005955-Howell1">[37]</xref>
###xml 686 690 683 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005955-Kim1">[20]</xref>
###xml 692 696 689 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005955-Rolen1">[21]</xref>
###xml 1319 1323 1316 1320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005955-Bheda1">[38]</xref>
While the roles of the multifunctional molecule beta-catenin in normal and cancer cells have been studied intensively, the potential impact of UCH L1 in oncogenesis is largely unexplored. Moreover, information on UCH L1 expression in different cancer cell lines is contradictory: on the one hand, silencing of UCH L1 expression by the methylation of its promoter was observed in some cancer cell lines and primary tumors [34], [35], [36]. On the other hand, there is growing evidence indicating that UCH L1 is overexpressed in a number of cancers [14], [15], [16], [17], [18], [19], [37], including recent data demonstrating the invasive capacity of malignant cells conferred by UCH L1 [20], [21]. The observation that expression and enzymatic activity of UCH L1 are required for its basic promoter activity opens speculation that as a deubiquitinating enzyme, UCH L1 might directly or indirectly regulate activity of different transcription factors involved in the regulation of its own promoter. Studies on UCH L1 functions in normal and cancer cells have just begun, and the physiological roles of this molecule in oncogenesis are unknown. Our recent studies demonstrate that proliferation and migration of cell lines stably expressing UCH L1 siRNAs is reduced, and the sensitivity to apoptotic agents was increased [38].
###end p 30
###begin p 31
###xml 225 231 222 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005955-g005">Fig. 5</xref>
UCH L1 appears to be a multi-functional protein that might contribute to more diverse cellular processes than were previously thought. Our results indicate that UCH L1 and beta-catenin/TCF can positively regulate each other (Fig. 5), supporting the hypothesis that UCH L1 has oncogenic potential, at least under some circumstances.
###end p 31
###begin title 32
Working hypothesis: UCH L1 up-regulates its expression through beta-catenin/TCF signaling.
###end title 32
###begin p 33
UCH L1 stabilizes beta-catenin through deubiquitination and up-regulates beta-catenin/TCF transcriptional activity. TCF4/Lef1 transcription factors directly bind to the uch l1 promoter and up-regulate UCH L1 RNA and protein expression.
###end p 33
###begin title 34
Materials and Methods
###end title 34
###begin title 35
Cell Lines and Reagents
###end title 35
###begin p 36
###xml 190 194 190 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005955-Kozbor1">[39]</xref>
###xml 319 320 313 314 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 45 50 <span type="species:ncbi:10090">mouse</span>
Human 293 embryonic kidney cells and NIH 3T3 mouse fibroblast cells were cultured in DMEM (Sigma) supplemented with 10% FBS (Sigma) and penicillin-streptomycin. Lymphoblastoid cell line KR4 [39] were cultured in RPMI 1640 medium plus 10% FBS and penicillin-streptomycin. All cells were maintained at 37degreesC in 5% CO2 in air. MG101, recombinant UCH L1, LiCl and Ubiquitin-AMC were purchased from Calbiochem, Boston Biochem, Sigma and Biomol respectively.
###end p 36
###begin title 37
Expression Plasmids
###end title 37
###begin p 38
###xml 864 868 861 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005955-Trowern1">[22]</xref>
###xml 892 897 <span type="species:ncbi:9606">human</span>
Wild-type pcDNA3-HA-UCH L1 was a gift from Dr. P. T. Lansbury. pcDNA3-HA-UCH L1 C90S and H161D mutants were generated by inserting a specific mutation at the Cys 90 and H161 sites in wild-type pcDNA3-HA-UCH L1 plasmid with the use of the Quik-Change Site Directed Mutagenesis Kit following the manufacturer's instructions (Stratagene). UCH L1 siRNA was obtained from OriGene Technologies, Inc, in the form of a shRNA expression plasmid. The control siRNA targeted against GFP and was also obtained from OriGene Technologies, Inc. pSuper-retro beta-catenin siRNA was constructed as described by the manufactor. TCF reporter plasmids, TOPFlash (optimal TCF-binding site) and FOPFlash (mutated TCF-binding site) were obtained from Upstate Biotechnology. Wild type and deltaN pcDNA3.1-Flag-TCF4 expression vectors were gift from H. Clevers. The UCH L1 promoter region [22] was PCR-amplified from human genomic DNA and cloned into Kpn I and Hind III sites of pGL3 basic plasmid and confirmed by sequencing. The siRNA or primers used in the experiments are as follows:
###end p 38
###begin p 39
###xml 16 50 16 50 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;TGTGGCACAATCGGACTTATTCACGCAGT 3&#8242;</named-content>
UCH L1 siRNA-1: 5'TGTGGCACAATCGGACTTATTCACGCAGT 3'
###end p 39
###begin p 40
###xml 19 48 19 48 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CCATGATGCCGTGGCACAGGAAGGCCAAT</named-content>
###xml 16 51 16 51 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; <named-content content-type="gene">CCATGATGCCGTGGCACAGGAAGGCCAAT</named-content> 3&#8242;</named-content>
UCH L1 siRNA-2: 5' CCATGATGCCGTGGCACAGGAAGGCCAAT 3'
###end p 40
###begin p 41
###xml 22 46 19 43 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;CCATGGAACCAGACAGAAA 3&#8242;</named-content>
beta-Catenin siRNA-1: 5'CCATGGAACCAGACAGAAA 3'
###end p 41
###begin p 42
###xml 22 46 19 43 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;CCCACTAATGTCCAGCGTT 3&#8242;</named-content>
beta-Catenin siRNA-2: 5'CCCACTAATGTCCAGCGTT 3'
###end p 42
###begin p 43
###xml 22 50 22 50 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;GGTACCAAAACGAACCTCGGTACTGG</named-content>
UCH L1 promoter-KpnI: 5'GGTACCAAAACGAACCTCGGTACTGG
###end p 43
###begin p 44
###xml 26 53 26 53 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;AAGCTTCTCACCTCGGGGTTGATCT</named-content>
UCH L1 promoter-Hind III: 5'AAGCTTCTCACCTCGGGGTTGATCT
###end p 44
###begin title 45
Immunofluorescence staining
###end title 45
###begin p 46
###xml 264 270 <span type="species:ncbi:9793">donkey</span>
###xml 309 315 <span type="species:ncbi:9986">rabbit</span>
###xml 353 358 <span type="species:ncbi:10090">mouse</span>
###xml 402 408 <span type="species:ncbi:9986">rabbit</span>
###xml 438 443 <span type="species:ncbi:10090">mouse</span>
###xml 628 632 <span type="species:ncbi:9925">goat</span>
###xml 638 644 <span type="species:ncbi:9986">rabbit</span>
###xml 675 679 <span type="species:ncbi:9925">goat</span>
###xml 685 690 <span type="species:ncbi:10090">mouse</span>
293 cells were grown on poly-L-Lysine (Sigma)-coated coverslips in 12-well dishes until 75% confluent. The cells were washed with PBS, fixed with 4% paraformaldehyde for 10 min, permeablized with 0.5% triton, washed three times with PBS and blocked with 5% normal donkey serum. Cells were then incubated with rabbit anti-UCH L1 antibody (Zymed, 1:100), mouse anti-beta-catenin antibody (Zymed, 1:100), rabbit anti-HA (Santa Cruz, 1:500), mouse anti-myc (Santa Cruz, 1:250) in 1:5 dilution of blocking solution for 1 h at 37degreesC and then washed three times with PBS. Next, cells were incubated with Alexafluor-594-conjugated goat anti-rabbit and Alexafluor-488-conjugated goat anti-mouse antibodies (Vector Laboratories, 1:500) for 1 h at 37degreesC, washed four times with PBS and mounted. Fluorescent images were created using Openlab software (Improvision Inc, MA, USA).
###end p 46
###begin title 47
Immunoblot
###end title 47
###begin p 48
Total cell lysates or immunocomplexes were resolved on SDS-PAGE, transferred to nitrocellulose membrane (Osmonics), blocked in 5% milk-Tris-buffered saline solution, and incubated at 4degreesC overnight with beta-catenin (1:1000, BD Transduction Laboratories, ), UCH L1 (1:7500, Zymed), GAPDH (1:5000, Sigma) antibodies. After washing with TBST for 10 min three times, the membrane was incubated with appropriate secondary antibody at room temperature for 1 h, washed three times with TBST as before, treated with SuperSignal (Pierce) detection reagents, and exposed to Kodak XAR-5 film.
###end p 48
###begin title 49
Immunoprecipitation
###end title 49
###begin p 50
###xml 118 119 118 119 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 121 122 121 122 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
Cells were lysed with buffer containing of 50 mM, pH 7.6 Tris-HCl, 1% NP-40, 0.25% Na-deoxycholate, 1 mM EDTA, 1 mM Na3VO4, 1 mM NaF and complete protease inhibitor mixture (Roche Diagnostics). After pre-clearing, cell lysates were incubated with beta-catenin (Zymed) or UCH L1 antibody (Zymed) or control Ig G for 1 h in 4degreesC; immune complexes were then incubated with protein A/G Sepharose beads (Santa Cruz) at 4degreesC overnight, washed four times with protein lysis buffer, and then eluted from the protein G-Sepharose with 2x Laemmli's buffer by boiling for 3 min.
###end p 50
###begin title 51
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
In vitro Deubiquitination Assays
###end title 51
###begin p 52
###xml 272 280 259 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In-vitro</italic>
###xml 539 545 <span type="species:ncbi:9986">rabbit</span>
###xml 794 799 <span type="species:ncbi:10090">mouse</span>
Endogenous beta-catenin was immunoprecipitated from 293 cells treated with 25 microM MG101 for 3 h with specific or control antibodies. Exogenous beta-catenin protein was translated in a TNT-coupled reticulocyte-lysate system (Promega) with pCMV beta-catenin as template. In-vitro translated beta-catenin (2 microl) was pre-incubated with 10 mM DTT for 15 min and for 2 h at 30degreesC in 20 microl of Ub reaction mixture containing: 50 mM Tris-HCl (pH 7.5), 50 mM NaCl, 2 mM Mg-ATP, 20 microM mammalian ubiquitin, 25 microM MG101, 100 nM rabbit E1 and 3 microl reticulocyte lysate, and then incubated with different amounts of UCH L1 recombinant protein (Boston Biochem) The reactions were stopped by adding equal volumes of 2x SDS sample loading buffer followed by Western blot analysis with mouse beta-catenin antibody (BD Pharmingen).
###end p 52
###begin title 53
Ubiquitin-AMC assay
###end title 53
###begin p 54
Overexpressed HA-UCH L1s were immunoprecipitated with HA antibody from 293 cells transfected with wild type, C90S and H161D uch l1 expression vectors. Immunoprecipitates were incubated with 1 microM of ubiquitin-AMC in reaction buffer containing 50 mM Tris pH 7.5, 2 mM ATP, and 2 mM DTT for 30 min at 37degreesC. Samples in triplicate were excited by exposure to light at a wavelength of 340 nm, and emission was measured at 460 nm.
###end p 54
###begin title 55
Stable cell lines
###end title 55
###begin p 56
For the establishment of UCH L1 siRNA and control siRNA stable lines, 293 cells were transfected with 2 microg of respective plasmid using the Fugene HD (Roche Diagnostics). Cells were passaged 24 h post transfections and selection was started 48 h post transfections. The cells were always maintained in the selective media containing 2 microg/ml puromycin (InvivoGen).
###end p 56
###begin title 57
Transient transfections and Luciferase reporter assay
###end title 57
###begin p 58
Cells were transiently transfected with total 2 microg of DNA with Fugene HD reagent (Roche Diagnostics) according to the manufacturer's instructions. Cells were collected 48 h post transfections.
###end p 58
###begin p 59
For Luciferase reporter assay, cells were plated in 6-well plates and transiently transfected with the use of Fugene with TCF reporter plasmids, TOPFlash or FOPFlash or Uchl1p-Luc promoter plasmid, and the effector plasmid. The total amount of DNA in all transfection was kept constant with empty vector. Luciferase activities were monitored in cell lysates with the use of Luciferase assay reagents (Promega) 48 h post transfections as described by the manufacturer. All reporter assay results presented here are from three independent experiments prepared in triplicate and have been normalized for beta-Gal activity.
###end p 59
###begin title 60
Reverse Transcriptase PCR
###end title 60
###begin p 61
HEK 293 and NIH 3T3 cells were treated with 25 mM LiCl for 24 h. Total RNA was extracted with the use of Agilent's Total RNA isolation mini kit (Agilent Technologies). 500 ng of total RNA were used to perform RT-PCR reactions with Qiagen's one step RT-PCR kit (Qiagen) as per manufacturer's instructions at an annealing temperature of 55degreesC. The samples were analyzed on 1% agarose gel. Primers used:
###end p 61
###begin p 62
###xml 8 34 8 34 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GGATGGCCACCTCTATGAAC-3&#8242;</named-content>
###xml 36 60 36 60 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AGACCTTGGCAGCGTCCT-3&#8242;</named-content>
###xml 69 96 69 96 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AGGTGAAGGTCGGAGTCAACG-3&#8242;</named-content>
###xml 98 124 98 124 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AGGGGTCATTGATGGCAACA-3&#8242;</named-content>
UCH L1: 5'-GGATGGCCACCTCTATGAAC-3', 5'-AGACCTTGGCAGCGTCCT-3', GAPDH: 5'-AGGTGAAGGTCGGAGTCAACG-3', 5'-AGGGGTCATTGATGGCAACA-3'.
###end p 62
###begin title 63
Quantitative Real Time PCR
###end title 63
###begin p 64
NIH 3T3 cells were treated with 25 mM LiCl for 6 h and RNA was isolated. Reverse transcription reaction was performed with 500 ng of total RNA using the iScript cDNA synthesis kit (Bio-Rad). A 1:25 dilution of cDNA was used in the QRT PCR reaction. QRT-PCR was carried out in a 15 microl reaction mixture with gene-specific primers for UCH L1 and GAPDH (also used in RT-PCR) using iQ-SYBR green kit (Bio-Rad). The PCR conditions were 95degreesC for 3 min, and 45 cycles of 95degreesC for 15 s, 55degreesC for 45 s on the ABI HT 7600 PCR instrument. All samples were assayed in triplicate. The differences in expression of UCH L1 were evaluated using a relative quantification method where the expression of UCH L1 was normalized to the reference gene GAPDH.
###end p 64
###begin title 65
Chromatin Immunoprecipitation
###end title 65
###begin p 66
###xml 1186 1212 1122 1148 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; CATTTACATTCATTCGTATT 3&#8242;</named-content>
###xml 1214 1240 1150 1176 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; CCTTTCACCATCCCAATTAC 3&#8242;</named-content>
###xml 1254 1280 1190 1216 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; ATGGGTTTCCAGAAACTTCG 3&#8242;</named-content>
###xml 1282 1308 1218 1244 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242; TGGTTGTGGAGACGGGATTT 3&#8242;</named-content>
ChIP assay was carried out using Active Motif ChIP-IT enzymatic kit. KR4 and 293 cells were fixed with 37% formaldehyde for 10 min at 37degreesC, the reaction was stopped with cold 0.125 M Glycine solution for 5 min at RT. The cells were then washed twice with PBS and collected in 0.5 ml of Digestion buffer with protease inhibitors. Chromatin with sheared with shearing enzyme for 10 min at 37degreesC to obtain an average of 200-1000 bp fragments. Sheared chromatin was incubated overnight at 4degreesC with Protein G magnetic beads, sheared chromatin, TCF4 antibody (Upstate, Clone 6H53). Immunoprecipitation was performed as per the manufacturer's instructions, cross-linking was reversed by incubated the immunoprecipitated complexes with 5 M NaCL for 2 h at 65degreesC followed by Proteinase-K treatment for 2 h at 42degreesC. PCR reaction was performed with 5 microl precipitated DNA using the primer pairs flanking consensus TCF sites in UCH L1 promoter. PCR conditions: one cycle, 95degreesC for 2 min; 30 cycles of 95degreesC for 30 s, 55degreesC for 30 s, and 72degreesC for 2 m, and a final extension at 72degreesC for 10 min. The primers used in the reaction are: Site 1 (5' CATTTACATTCATTCGTATT 3', 5' CCTTTCACCATCCCAATTAC 3') and Site 2 (5' ATGGGTTTCCAGAAACTTCG 3', 5' TGGTTGTGGAGACGGGATTT 3').
###end p 66
###begin title 67
Site Directed Mutagenesis
###end title 67
###begin p 68
###xml 162 169 162 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8220;TTTGA&#8221;</italic>
###xml 185 192 185 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8220;CCTTG&#8221;</italic>
###xml 531 534 531 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dpn</italic>
The UCH L1 promoter was mutated at different TCF4/Lef1 binding sites using the Quik-Change Site Directed Mutagenesis Kit (Stratagene). The TCF4/Lef1 binding site "TTTGA" was mutated to "CCTTG" and exactly same mutations were introduced at both the binding sites. Four nucleotide changes were introduced into the parental plasmid by oligonucleotide primers carrying the specific mutations. The promoter was mutated at a single TCF4/Lef1 binding site or both binding sites at a time. The parental DNA template was then digested with DpnI. All mutations and the integrity of the remainder of the promoter were confirmed by DNA sequencing.
###end p 68
###begin title 69
References
###end title 69
###begin article-title 70
Ubiquitin as a central cellular regulator.
###end article-title 70
###begin article-title 71
The Yin-Yang of TCF/beta-catenin signaling.
###end article-title 71
###begin article-title 72
Balancing cell adhesion and Wnt signaling, the key role of beta-catenin.
###end article-title 72
###begin article-title 73
Catenins, Wnt signaling and cancer.
###end article-title 73
###begin article-title 74
Wnt/beta-catenin signaling in development and disease.
###end article-title 74
###begin article-title 75
Regulation of Wnt signaling by protein-protein interaction and post-translational modifications.
###end article-title 75
###begin article-title 76
###xml 0 18 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Epstein-Barr virus activates beta-catenin in type III latently infected B lymphocyte lines: association with deubiquitinating enzymes.
###end article-title 76
###begin article-title 77
The deubiquitinating enzyme Fam interacts with and stabilizes beta-catenin.
###end article-title 77
###begin article-title 78
Substrate binding and catalysis by ubiquitin C-terminal hydrolases: identification of two active site residues.
###end article-title 78
###begin article-title 79
Ubiquitin-proteasome system and Parkinson's diseases.
###end article-title 79
###begin article-title 80
The functions of UCH-L1 and its relation to neurodegenerative diseases.
###end article-title 80
###begin article-title 81
The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility.
###end article-title 81
###begin article-title 82
Ubiquitin carboxy-terminal hydrolase L1 binds to and stabilizes monoubiquitin in neuron.
###end article-title 82
###begin article-title 83
PGP9.5 as a candidate tumor marker for non-small-cell lung cancer.
###end article-title 83
###begin article-title 84
###xml 93 98 <span type="species:ncbi:9606">human</span>
Expression of protein gene product 9.5 (PGP9.5)/ubiquitin-C-terminal hydrolase 1 (UCHL-1) in human myeloma cells.
###end article-title 84
###begin article-title 85
Gefitinib-responsive EGFR-positive colorectal cancers have different proteome profiles from non-responsive cell lines.
###end article-title 85
###begin article-title 86
###xml 91 96 <span type="species:ncbi:9606">human</span>
Activity-based ubiquitin-specific protease (USP) profiling of virus-infected and malignant human cells.
###end article-title 86
###begin article-title 87
###xml 66 71 <span type="species:ncbi:9606">human</span>
Characterization of genes associated with different phenotypes of human bladder cancer cells.
###end article-title 87
###begin article-title 88
###xml 101 109 <span type="species:ncbi:9606">patients</span>
High expression of ubiquitin carboxy-terminal hydrolase-L1 and -L3 mRNA predicts early recurrence in patients with invasive breast cancer.
###end article-title 88
###begin article-title 89
Ubiquitin C-terminal hydrolase-L1 is a key regulator of tumor cell invasion and metastasis.
###end article-title 89
###begin article-title 90
The Ubiquitin C-terminal Hydrolase UCH-L1 regulates B-cell proliferation and integrin activation.
###end article-title 90
###begin article-title 91
###xml 89 94 <span type="species:ncbi:9606">human</span>
A bi-functional activator/repressor element required for transcriptional activity of the human UCH-L1 gene assembles a neuron-specific protein: single-strand DNA complex.
###end article-title 91
###begin article-title 92
Identification of evolutionary conserved regulatory sequences in the 5' untranscribed region of the neural-specific ubiquitin C-terminal hydrolase (PGP9.5) gene.
###end article-title 92
###begin article-title 93
###xml 21 26 <span type="species:ncbi:9606">human</span>
The structure of the human gene encoding protein gene product 9.5 (PGP9.5), a neuron-specific ubiquitin C-terminal hydrolase.
###end article-title 93
###begin article-title 94
Cell cycle regulation by the B-Myb transcription factor.
###end article-title 94
###begin article-title 95
###xml 19 25 <span type="species:ncbi:10090">murine</span>
Stimulation of the murine Uchl1 gene promoter by the B-Myb transcription factor.
###end article-title 95
###begin article-title 96
Targeting of host-cell ubiquitin pathways by viruses.
###end article-title 96
###begin article-title 97
Interaction and colocalization of PGP9.5 with JAB1 and p27(Kip1).
###end article-title 97
###begin article-title 98
Identification and cloning of TCF-1, a T lymphocyte-specific transcription factor containing a sequence-specific HMG box.
###end article-title 98
###begin article-title 99
Mood stabilizers, glycogen synthase kinase-3beta and cell survival.
###end article-title 99
###begin article-title 100
LEF-1, a nuclear factor coordinating signaling inputs from wingless and decapentaplegic.
###end article-title 100
###begin article-title 101
TCF transcription factors: molecular switches in carcinogenesis.
###end article-title 101
###begin article-title 102
Glycogen synthase kinase 3: a key regulator of cellular fate.
###end article-title 102
###begin article-title 103
PGP9.5 promoter methylation is an independent prognostic factor for esophageal squamous cell carcinoma.
###end article-title 103
###begin article-title 104
###xml 31 36 <span type="species:ncbi:9606">human</span>
Silencing of the UCHL1 gene in human colorectal and ovarian cancers.
###end article-title 104
###begin article-title 105
Identification of methylation-silenced genes in colorectal cancer cell lines: Genomic screening using oligonucleotide arrays.
###end article-title 105
###begin article-title 106
Accuracy of combined protein gene product 9.5 and parafibromin markers for immunohistochemical diagnosis of parathyroid carcinoma.
###end article-title 106
###begin article-title 107
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 51 69 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Human hybridomas constructed with antigen-specific Epstein-Barr virus-transformed cell lines.
###end article-title 107
###begin p 108
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 108
###begin p 109
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: Grant #2-P01-CA19014-26, National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 109

